glp 1 semaglutide and tirzepatide vs for Weight Loss GLP-1 medications are marketed to

Fatigue during initial Ozempic treatment commonly results from gastrointestinal side effects such as nausea, reduced appetite leading to lower caloric intake, or the body adjusting to improved metabolic control

Clinical trials showed participants using tirzepatide lost significantly more weight than those on semaglutide alone, with some losing over 20% of body weight within 68 weeks

This sounds obvious, but the temptation exists, especially when someone misses a dose and feels their appetite returning

It is also necessary to know what comorbidities are described in each model, as the selection may depend on the possibility of replicating these comorbidities